Drug Discovery for Parasitic Diseases (A5) is organized by Keystone Symposia on Molecular and Cellular Biology and would be held during Jan 24 - 28, 2016 at Granlibakken Tahoe - Tahoe City, California, United States of America.
his conference will showcase cutting-edge anti-parasitic drug discovery programs that illustrate the path from parasite biology to lead identification and from optimization to candidate selection. It will emphasize the need for coordinated integration of programs in medicinal chemistry, parasite biology, pharmacokinetics and safety assessment. It will feature emerging technologies such as chemical biology, chemoproteomics, chemical informatics, genomics, transcriptomics and metabolomics that are facilitating drug discovery. It will also discuss the current status of anti-parasitic drug resistance and advances in our understanding of mechanisms of resistance.